Zyla Life Sciences Total Assets
Zyla Life Sciences had Total Assets of $229.48 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2020-05-14
- 2020-03-31: Assets $229.48M.
- 2019-12-31: Assets $230.39M.
- 2019-09-30: Assets $239.05M.
- 2019-06-30: Assets $235.57M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2020-03-31 | $229.48M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $230.39M 10-Q · filed 2020-05-14 | |
| 2019-09-30 | $239.05M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $235.57M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $264.82M 10-Q · filed 2019-05-17 | |
| 2019-02-01 | $254.15M 10-Q · filed 2020-05-14 | |
| 2019-01-31 | $59.91M 10-Q · filed 2020-05-14 | $254.15M 10-Q · filed 2019-05-17 |
| 2018-12-31 | $61.93M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $72.61M 10-Q · filed 2018-11-19 | |
| 2018-06-30 | $99.98M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $111.30M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $119.86M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $131.19M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $118.02M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $135.33M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $114.86M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $134.07M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $133.57M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $155.24M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $172.42M 10-K · filed 2017-03-13 | |
| 2015-09-30 | $193.96M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $130.83M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $86.84M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $60.57M 10-K · filed 2016-03-11 | |
| 2014-09-30 | $65.87M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $75.13M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $81.16M 10-Q · filed 2014-06-11 | |
| 2013-12-31 | $20.36M 10-K · filed 2015-03-16 |